Factor XI Inhibitors: Anticoagulation with Minimal Bleeding?
The development of new antithrombotic agents is fundamentally driven by the need to effectively prevent dangerous blood clots (thrombosis) while
Read More
Uncategorized
Extended Anticoagulation for Venous Thromboembolism
Venous thromboembolism (VTE) encompasses pulmonary embolism and deep vein thrombosis. These conditions carry a significant risk of recurrence, particularly following
Read More
Anticoagulation for Peripheral Artery Disease
Studies have shown that rivaroxaban, an anticogulant marketed as Xarelto, improves outcomes of patients with peripheral artery disease. The concept
Read More